News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
GENSCRIPT BIO Spikes 19% as Legend Biotech Corporation (LEGN.US) Announces Positive Prelim Clinical Data for Lymphoma Therapy
GENSCRIPT BIO (01548.HK) opened 14.99% higher today and once reached a peak of HKD15.6. It last stood at HKD14.48, up 19.28%, with a turnover of 29.861 million shares, involving HK...
Reset
Send
The window will close in 5 seconds
GENSCRIPT BIO Spikes 19% as Legend Biotech Corporation (LEGN.US) Announces Positive Prelim Clinical Data for Lymphoma Therapy
Close
Recommend
7
Positive
8
Negative
8
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

GENSCRIPT BIO (01548.HK)  -0.420 (-3.130%)    Short selling $172.85M; Ratio 16.474%   opened 14.99% higher today and once reached a peak of HKD15.6. It last stood at HKD14.48, up 19.28%, with a turnover of 29.861 million shares, involving HKD437 million.

Legend Biotech Corporation (LEGN.US)      , an associate of the Company, announced that promising preliminary clinical data for LB2501, its investigational in vivo CD19/CD20 dual-targeting CAR-T cell therapy, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL), will be presented during a late-breaking session at the European Hematology Association (EHA) 2026 Congress.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-03 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.